4.5 Article

Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction

期刊

PLACENTA
卷 42, 期 -, 页码 1-8

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.placenta.2016.03.010

关键词

Fetal growth restriction; Placental growth factor; Placental dysfunction; Placental lesions; Diagnosis

资金

  1. Canadian Institutes of Health Research [MOC 119545]
  2. Child and Family Research Institute
  3. British Columbia Women's Hospital and Health Centre
  4. Michael Smith Foundation for Health Research
  5. Auckland Healthcare
  6. Health Research Council of New Zealand
  7. Lottery Health Grants Board
  8. Maurice and Phyllis Paykel Trust
  9. Alere International
  10. Bill & Melinda Gates Foundation [OPP1017337]
  11. BC Women's and Children's Department of Pathology and Laboratory Medicine
  12. Department of Anatomical Pathology at the Children's Hospital of Eastern Ontario Department of Anatomical Pathology
  13. Department of Anatomy with Radiology at the University of Auckland
  14. National Institute for Health Research [RP-2014-05-019, PB-PG-0214-33054, CS-2013-13-009] Funding Source: researchfish
  15. National Institutes of Health Research (NIHR) [PB-PG-0214-33054] Funding Source: National Institutes of Health Research (NIHR)

向作者/读者索取更多资源

Introduction: Discriminating between placentally-mediated fetal growth restriction and constitutionally-small fetuses is a challenge in obstetric practice. Placental growth factor (PlGF), measurable in the maternal circulation, may have this discriminatory capacity. Methods: Plasma PlGF was measured in women presenting with suspected fetal growth restriction (FGR; ultrasound fetal abdominal circumference <10th percentile for gestational age) at sites in Canada, New Zealand and the United Kingdom. When available, placenta tissue underwent histopathological examination for lesions indicating placental dysfunction, blinded to PlGF and clinical outcome. Lesions were evaluated according to pre-specified severity criteria and an overall severity grade was assigned (0-3, absent to severe). Low PlGF (concentration <5th percentile for gestational age) to identify placental FGR (severity grade >= 2) was assessed and compared with routine parameters for fetal assessment. For all cases, the relationship between PlGF and the sampling-to-delivery interval was determined. Results: Low PlGF identified placental FGR with an area under the receiver-operator characteristic curve of 0.96 [95% CI 0.93-0.98], 98.2% [95% CI 90.5-99.9] sensitivity and 75.1% [95% CI 67.6-81.7] specificity. Negative and positive predictive values were 99.2% [95% CI 95.4-99.9] and 58.5% [95% CI 47.9-68.6], respectively. Low PlGF outperformed gestational age, abdominal circumference and umbilical artery resistance index in predicting placental FGR. Very low PlGF (<12 pg/mL) was associated with shorter sampling-to-delivery intervals than normal PlGF (13 vs. 29.5 days, P < 0.0001). Discussion: Low PlGF identifies small fetuses with significant underlying placental pathology and is a promising tool for antenatal discrimination of FGR from fetuses who are constitutionally-small. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据